Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.

Diabetes care - 1 Aug 2008

Skupien Jan, Gorczynska-Kosiorz Sylwia, Klupa Tomasz, Wanic Krzysztof, Button Eric A, Sieradzki Jacek, Malecki Maciej T

Abstract excerpt

OBJECTIVE: 1,5-anhydroglucitol (1,5-AG) is a short-term marker of metabolic control in diabetes. Its renal loss is stimulated in hyperglycemic conditions by glycosuria, which results in a lowered plasma concentration. As a low renal threshold for glucose has been described in hepatocyte nuclear factor-1alpha (HNF-1alpha) maturity-onset diabetes of the young (MODY), the 1,5-AG level may be altered in these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Deoxyglucose
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatocyte Nuclear Factor 1-alpha

Share to Mutation

Share to Poland

Share to Reference Values

Share to Registries

Share to Sex Characteristics

Source

Open in PubMed Open full text

Identifiers

PMID: 18492944
DOI: 10.2337/dc07-2334
PMCID: PMC2494661

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.PMID 18492944Read ↗

Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.Semantic proximity Read ↗

Circulating 1,5-Anhydroglucitol as a Biomarker of ß-cell Mass Independent of a Diabetes Phenotype in Human Subjects.Semantic proximity Read ↗

A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1α (HNF-1α) geneSemantic proximity Read ↗

A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.Semantic proximity Read ↗

Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers.Semantic proximity Read ↗

The genetic abnormality in the beta cell determines the response to an oral glucose load.Semantic proximity Read ↗

Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism.Semantic proximity Read ↗

Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?Semantic proximity Read ↗

Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity onset diabetes of the young.Semantic proximity Read ↗

Determination of the renal threshold for glucose excretion in Familial Renal Glucosuria.Semantic proximity Read ↗

HNF4A mutation: switch from hyperinsulinaemic hypoglycaemia to maturity-onset diabetes of the young, and incretin response.Semantic proximity Read ↗

Development of an exoglycosidase plate-based assay for detecting α1-3,4 fucosylation biomarker in individuals with HNF1A-MODY.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.